Evaluation of augmentation index and pulse wave velocity measurements in central retinal vein occlusion patients with and without hypertension-Reference-Cited by-同舟云学术

Evaluation of augmentation index and pulse wave velocity measurements in central retinal vein occlusion patients with and without hypertension

Published:2022-01-27 Issue:4 Volume:42 Page:1347-1354
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Karadağ Mehmet Fatih^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s10792-022-02237-1.pdf

Reference39 articles.

1. Mitchell P, Smith W, Chang A (1996) Prevalence and associations of retinal vein occlusion in Australia. The blue mountains eye study. Arch Ophthalmol 114:1243–1247. https://doi.org/10.1001/archopht.1996.01100140443012

2. Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the beaver dam eye study. Trans Am Ophthalmol Soc 98:133–141

3. Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA (1998) Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology 105:765–771. https://doi.org/10.1016/s0161-6420(98)95012-6

4. Tsaloumas MD, Kirwan J, Vinall H, O’Leary MB, Prior P, Kritzinger EE, Dodson PM (2000) Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye (Lond) 14:821–827. https://doi.org/10.1038/eye.2000.230

5. Martin SC, Butcher A, Martin N, Farmer J, Dobson PM, Bartlett WA, Jones AF (2002) Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86:774–776. https://doi.org/10.1136/bjo.86.7.774